Final answer:
A nurse should report an increased anti-Xa level in a female patient with severe renal impairment receiving enoxaparin, as it suggests an increased risk for bleeding.
Step-by-step explanation:
The laboratory value due to enoxaparin that a nurse should report to the healthcare provider for a female client with severe renal impairment is an increased anti-Xa level.
Enoxaparin is a low molecular weight heparin that is used to prevent and treat thrombosis and is monitored by measuring anti-Xa levels, especially in patients with renal impairment, as they are at a higher risk for bleeding due to accumulation of the drug.
The therapeutic range of anti-Xa for patients on enoxaparin is typically between 0.5 and 1.0 IU/mL.
Values higher than the therapeutic range could indicate an increased risk for bleeding.
Additionally, due to the renal impairment, it's important to closely monitor the patient's platelet count for any signs of heparin-induced thrombocytopenia (HIT), a serious complication of heparin therapy.